儿童起病表现为脑膜脑炎的抗髓鞘少突胶质细胞糖蛋白抗体相关疾病的临床、影像及复发分析:单中心回顾性研究
单中心回顾性研究纳入2018年1月至2024年1月诊断为MOGAD且起病表现为脑膜脑炎的53例儿童,21例(40%)呈多相病程。MRI以额叶受累(85%)、皮层FLAIR高信号(87%)和皮层下FLAIR低信号(96%)多见,受累脑叶数多为复发的独立危险因素(P=0.010,OR=1.547)。
要点
- 儿童MOG抗体相关脑膜脑炎中,皮层下FLAIR低信号(「暗白质」征)见于96%的患儿,是突出影像征象。
- 癫痫病因不明患儿若MRI同时出现脑膜皮层异常与「暗白质」征,高度提示该表型。
- 受累脑叶数越多,复发风险越高(P=0.010,OR=1.547)。
核心结论
- 皮层下FLAIR低信号(「暗白质」征)是儿童MOG抗体相关脑膜脑炎的突出影像表现;脑膜皮层病灶负荷越广,复发风险越高。
研究设计与样本
- 单中心回顾性研究,纳入2018年1月至2024年1月本院诊断MOGAD且起病表现为脑膜脑炎的儿童53例(占MOGAD队列23%,起病年龄<18岁,年龄范围2.7-16.4岁,中位年龄11.4岁,女性21例),按有无临床复发分为单相组和多相组。
关键影像表现/征象
- MRI单侧受累35例(66%),双侧受累18例(34%)。
- 额叶受累45例(85%)为最常见MRI模式。
- T2-FLAIR上皮层高信号46例(87%),柔脑膜线样高信号28例(53%),皮层下FLAIR低信号51例(96%)。
- 弥散受限少见(4例,8%);脑膜强化见于88%(38/43)。
诊断标准与关键数值
- 多相组较单相组顶叶受累比例更高(P=0.023)。
- 多相组较单相组枕叶受累比例更高(P=0.016)。
- 多相组较单相组半球受累比例更高(P=0.023)。
- 多相组较单相组受累脑叶中位数更多(P=0.011)。
- 校正年龄和性别后,受累脑叶数更多为复发的独立危险因素(P=0.010,OR=1.547)。
临床应用与阅片要点
- 儿童癫痫病因不明时,MRI同时出现脑膜皮层异常与「暗白质」征高度提示MOG抗体相关脑膜脑炎表型。
- 报告中应描述受累脑叶数目及范围,受累脑叶数更多与更高复发风险相关(P=0.010,OR=1.547)。
局限性
- 本文为单中心回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is a neuroinflammatory disorder with a heterogeneous phenotype. MOGAD, presenting with meningoencephalitis, has been described, with limited data on the clinical and radiographic features in children.
OBJECTIVE: We aimed to comprehensively investigate the clinical and radiographic characteristics of the MOG antibody-associated meningoencephalitis in children and to identify any magnetic resonance imaging (MRI) markers associated with relapse.
MATERIALS AND METHODS: This was a single-center, retrospective study. All data for pediatric patients (age of onset < 18 years) diagnosed with MOGAD at our hospital from January 2018 to January 2024 were reviewed. Patients with initial clinicoradiological constellations consistent with meningoencephalitis were included in the analysis and subsequently classified into monophasic and multiphasic groups based on the presence or absence of clinical relapses.
RESULTS: A total of 53 children (23% of our MOGAD cohort; age range, 2.7-16.4 years; median age, 11.4 years; 21 females) were included; among them, 21 (40%) presented with a multiphasic course. Within the entire cohort, the common clinical manifestations included seizures (37 (70%)), headache (35 (66%)), and fever (31 (58%)). MRI revealed unilateral involvement in 35 (66%) and bilateral involvement in 18 (34%). Frontal lobe involvement (45 (85%)) was the most predominant MRI pattern. On T2-weighted fluid-attenuated inversion recovery (FLAIR) images, cortical hyperintensity was observed in 46 (87%) patients, leptomeningeal linear hyperintensity in 28 (53%), and subcortical FLAIR hypointensity in 51 (96%). Diffusion restriction (4 (8%)) was uncommon. Meningeal enhancement was observed in 88% (38/43). Compared with the monophasic group, the multiphasic group demonstrated greater proportions of parietal (P = 0.023), occipital lobe (P = 0.016), and hemispheric (P = 0.023) involvement, as well as a greater median number of involved lobes (P = 0.011). Multivariate logistic regression analysis, adjusted for age and sex, revealed that a greater number of involved lobes was an independent risk factor for relapse (P = 0.010, odds ratio (OR) = 1.547).
CONCLUSIONS: Subcortical FLAIR hypointensity, also known as the "dark white matter" sign, is a particularly prominent imaging finding in children with MOG antibody-associated meningoencephalitis. In pediatric patients with epilepsy of unknown etiology, the concurrent presence of meningocortical abnormalities and the "dark white matter" sign on MRI is highly suggestive of this phenotype. A more extensive meningocortical lesion burden is associated with a higher risk of relapse.
引用
- Tang X, Zhang W, Zhou A, et al. Clinical, imaging, and recurrence analysis of myelin oligodendrocyte glycoprotein antibody-associated disease with initial presentation as meningoencephalitis in children: a single-center retrospective study. Pediatr Radiol. 2025. PMID: 40464908. doi:10.1007/s00247-025-06269-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。